Tokenized equities just posted $3.57 billion in daily trading volume-a record for a sector that barely existed two years ago. Injective, the Layer 1 blockchain built for financial applications, is at the center of that surge.
Injective's iAssets framework creates synthetic trackers for major companies like Nvidia, Apple, and Amazon-tradable as perpetual futures on the Helix decentralized exchange. These are not actual shares but price-tracking instruments referencing real equity prices via oracles. Leverage goes up to 25x, and access is permissionless, bypassing traditional brokerage requirements.
A partnership with Republic tokenizes pre-IPO equity exposure, generating $1 billion in trading volume within 30 days. Another deal with Musicow tokenizes music intellectual property rights, showing the infrastructure as a general-purpose RWA engine.
Regulatory tailwinds are building: CFTC-regulated futures for Injective's INJ token began trading on Bitnomial in April 2026, and Nasdaq has received approvals for tokenized trading initiatives. The $3.57 billion daily volume demonstrates how onchain synthetics eliminate global stock market frictions-different schedules, intermediaries, and geographical restrictions.
Risks remain: regulators could classify synthetic trackers as securities, and oracle failures could amplify losses at 25x leverage.